Described herein are bispecific binding proteins that specifically bind to an antigen expressed on a target cell and an antigen expressed on a T-cell, e.g., human CD33 and human CD3 and therapeutically effective dosing regimens for immunotherapy of cancers, diseases and conditions such as acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and solid tumor cancers.
